PH27225A - Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols - Google Patents

Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Info

Publication number
PH27225A
PH27225A PH37315A PH37315A PH27225A PH 27225 A PH27225 A PH 27225A PH 37315 A PH37315 A PH 37315A PH 37315 A PH37315 A PH 37315A PH 27225 A PH27225 A PH 27225A
Authority
PH
Philippines
Prior art keywords
conjugates
coupled
molecular weight
high molecular
superoxide dismutase
Prior art date
Application number
PH37315A
Other languages
English (en)
Inventor
Mark Saifer
Ralph Somack
L David Williams
Original Assignee
Ddi Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddi Pharmaceuticals filed Critical Ddi Pharmaceuticals
Publication of PH27225A publication Critical patent/PH27225A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PH37315A 1987-08-03 1988-07-29 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols PH27225A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03

Publications (1)

Publication Number Publication Date
PH27225A true PH27225A (en) 1993-05-04

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37315A PH27225A (en) 1987-08-03 1988-07-29 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols

Country Status (17)

Country Link
EP (1) EP0377613B1 (ja)
JP (1) JP2515389B2 (ja)
KR (1) KR920001426B1 (ja)
CN (1) CN1020458C (ja)
AU (1) AU608901B2 (ja)
CA (1) CA1309046C (ja)
DE (1) DE3876997T2 (ja)
DK (1) DK160842C (ja)
ES (1) ES2007536A6 (ja)
HU (1) HU203783B (ja)
IE (1) IE64284B1 (ja)
IL (1) IL87177A (ja)
NZ (1) NZ225481A (ja)
PH (1) PH27225A (ja)
RU (1) RU1776275C (ja)
WO (1) WO1989001033A1 (ja)
ZA (1) ZA885249B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136595T5 (es) † 1989-04-19 2004-04-01 Enzon, Inc. Carbonatos activos de oxidos de polialquileno para la modificacion de polipeptidos.
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
EP0598037A1 (en) * 1991-08-05 1994-05-25 Sanofi Buffered formulation of peg-sod
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
CA2332334A1 (en) * 1998-06-23 1999-12-29 Novozymes A/S A polypeptide-polymer conjugate
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
CN1315997A (zh) * 1998-07-17 2001-10-03 诺沃奇梅兹有限公司 具有改进的洗涤性能的多肽－聚合物缀合物
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
JP5207590B2 (ja) 2002-12-26 2013-06-12 マウンテン ビュー ファーマシューティカルズ，インコーポレイテッド 増強された生物学的能力を有するインターフェロン−βのポリマー結合体
CN1820024B (zh) 2003-05-12 2011-06-22 阿费麦克斯公司 新的聚(乙二醇)修饰的化合物及其用途
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
ES2007536A6 (es) 1989-06-16
JP2515389B2 (ja) 1996-07-10
CN1020458C (zh) 1993-05-05
AU608901B2 (en) 1991-04-18
DE3876997D1 (de) 1993-02-04
ZA885249B (en) 1989-04-26
DK160842B (da) 1991-04-22
EP0377613B1 (en) 1992-12-23
DK392789D0 (da) 1989-08-10
DE3876997T2 (de) 1993-04-29
CA1309046C (en) 1992-10-20
HU203783B (en) 1991-09-30
IL87177A0 (en) 1988-12-30
DK392789A (da) 1989-08-10
CN1031088A (zh) 1989-02-15
JPH02504341A (ja) 1990-12-13
DK160842C (da) 1991-10-14
RU1776275C (ru) 1992-11-15
IE64284B1 (en) 1995-07-26
HUT52816A (en) 1990-08-28
WO1989001033A1 (en) 1989-02-09
AU2326888A (en) 1989-03-01
IE882206L (en) 1989-02-03
EP0377613A1 (en) 1990-07-18
NZ225481A (en) 1990-11-27
KR890701736A (ko) 1989-12-21
KR920001426B1 (ko) 1992-02-13
IL87177A (en) 1992-08-18

Similar Documents

Publication Publication Date Title
ZA885249B (en) Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
GB2124445B (en) Improvements in or relating to transimpedance amplifiers
EP0187974A3 (en) Shaped polyethylene articles of intermediate molecular weight and high modulus
EP0296445A3 (en) Improvements to air springs
JPS6466215A (en) High molecular weight polystyrene, its production and polymer blend composition of polyphenylene ether and impact resistant polystyrene
EP0355348A3 (en) Superoxide dismutase composition
IL87880A0 (en) Covalent oligonucleotide-horseradish peroxidase conjugates and their preparation
IL87168A0 (en) Pharmaceutical compositions containing somatotrophin releasing factor
EP0504136A4 (en) Tolerogenic immunoglobulin-protein conjugates
GB8919661D0 (en) Superoxide dismutase-catalase conjugates
DE3367403D1 (en) Single stage production of improved high molecular weight polybenzimidazole
GB8601128D0 (en) Imparting movement to baby cradle
EP0292321A3 (en) Acylated derivative of superoxide dismutase and composition containing same
GB2055373B (en) Preparation of vicinal alkylene glycols
GB2207352B (en) Use of papaverine in formulating anti-viral compositions
GB8613315D0 (en) Preparing conjugates of metalloproteins
ZA881743B (en) Human manganese superoxide dismutase(hmn-sod)
IE862324L (en) Cloned superoxide dismutase
IE873096L (en) Preparation of low molecular weight glucosaminoglycans
GB9026229D0 (en) Tolerogenic conjugates for suppressing immune responses
GR871647B (en) Personal flat pocket glass
IE900496L (en) Production of superoxide dismutase in yeast cells
IL94791A0 (en) High molecular weight sodium hyaluronate
ZA831907B (en) Conjugates of haptenes and muramyl-peptides,endowed with immunogenic activity and compositions containing them
PH24201A (en) A superoxide dismutase